⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL933127 | 0.98 | — | — | |
| SCHEMBL28858341 | 0.96 | — | — | |
| Bicarbonate SCHEMBL28210330 | 0.92 | — | — | |
| SCHEMBL27674320 | 0.82 | — | — | |
| SCHEMBL933257 | 0.80 | — | — | |
| SCHEMBL27971657 | 0.80 | TSHR (0.44) | — | |
| SCHEMBL34471209 | 0.79 | — | — | |
| SCHEMBL4436164 | 0.78 | — | — | |
| SCHEMBL18281302 | 0.78 | — | — | |
| Acetic Acid SCHEMBL27989984 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676488-A1 | TREATMENT OF PARKINSON'S DISEASE IN A PATIENT USING A GLUCOCEREBROSIDASE ACTIVATOR | Bial-R&D Investments, S.A. (PT) | 2026-01-14 | — | — | EP | claimed |
| CN-120202200-A | Oxo-isoindolinyl substituted tetrahydropyrimidinedione-based compounds and applications thereof | 标新生物医药科技(上海)有限公司 | 2025-06-24 | — | — | CN | claimed |
| US-20240425510-A1 | PROCESS FOR THE PREPARATION OF ZANUBRUTINIB | OLON S.P.A. (IT) | 2024-12-26 | — | — | US | claimed |
| WO-2024191312-A1 | TREATMENT OF PARKINSON'S DISEASE IN A PATIENT USING A GLUCOCEREBROSIDASE ACTIVATOR | BIAL – R&D Investments, S.A. (PT) | 2024-09-19 | — | — | WO | claimed |
| EP-4416149-A1 | PROCESS FOR THE PREPARATION OF ZANUBRUTINIB | OLON S.p.A. (IT) | 2024-08-21 | — | — | EP | claimed |
| EP-4247382-A1 | METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING BTK INHIBITORS | BeiGene Switzerland GmbH (CH) | 2023-09-27 | — | — | EP | claimed |
| WO-2023062504-A1 | PROCESS FOR THE PREPARATION OF ZANUBRUTINIB | OLON S.P.A. (IT) | 2023-04-20 | — | — | WO | claimed |
| WO-2023284703-A1 | PROTEIN DEGRADATION COMPOUND DESIGNED ON THE BASIS OF BRUTON'S TYROSINE KINASE LIGAND AND APPLICATION THEREOF | 标新生物医药科技(上海)有限公司 | 2023-01-19 | — | — | WO | claimed |
| CN-115417874-A | Radioisotope carbon-14 labeled zebrafenib and preparation method thereof | 浙江爱索拓标记医药科技有限公司 | 2022-12-02 | — | — | CN | claimed |
| US-20220306588-A1 | BEZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | MERCK PATENT GMBH (DE) | 2022-09-29 | — | — | US | claimed |
| CN-1826345-A | Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands | NEUROGEN CORP A CORP OF THE ST (US) | 2006-08-30 | — | — | CN | claimed |
| EP-1689752-A1 | PYRAZOLOPYRIMIDINES | Pfizer Limited (GB) | 2006-08-16 | — | — | EP | claimed |
| WO-2005123738-A1 | PYRRAZOLO-PYRIMIDINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2005-12-29 | — | — | WO | claimed |
| EP-1572113-A2 | CALCIUM RECEPTOR MODULATING COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2005-09-14 | — | — | EP | claimed |
| WO-2005049617-A1 | PYRAZOLOPYRIMIDINES | PFIZER LIMITED (GB) | 2005-06-02 | — | — | WO | claimed |
| CN-1496262-A | Triazolo [4, 5-d ] pyrimidine derivatives and their use as purinergic receptor antagonists | О | 2004-05-12 | — | — | CN | claimed |
| WO-2004019933-A1 | METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS | PHARMACIA & UPJOHN COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004017908-A2 | CALCIUM RECEPTOR MODULATING COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-03-04 | — | — | WO | claimed |
| CN-1027263-C | Process for preparing pyridopyrimidine derivatives | CHINOIN CYOGYSZER ES VEGYSEZET (HU) | 1995-01-04 | — | — | CN | claimed |
| CN-1036762-A | Pyridopyrimidine derivatives contains the pharmaceutical composition and the method for making thereof of this derivative | CHINOIN GYOGYSZER ES VEGYESZET (HU) | 1989-11-01 | — | — | CN | claimed |